New research reveals independent origins of the sickle mutation in Africa and Asia. Alpha-thalassaemia frequency is underestimated, and malaria resistance in haemoglobinopathies is better understood.
Related Concept Videos
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Haemoglobinopathies are significant health issues in developing nations.
Modern research approaches are yielding new insights into these disorders.
Previous understanding of sickle mutation origins and thalassaemia prevalence was incomplete.
Purpose:
To review key haemoglobinopathies in developing countries using updated research.
To investigate the independent origins of the sickle mutation.
To elucidate the genetic basis of Plasmodium falciparum resistance in sickle cell disorders and thalassaemia.
Summary:
The sickle mutation arose independently in West Africa, distinct from East Africa and Asia. Alpha-thalassaemia prevalence is higher than previously thought in Mediterranean and African regions. Significant progress has been made in understanding the genetic resistance to malaria associated with sickle cell disorders and thalassaemia.
Molecular investigations reveal the heterogeneity of alpha- and beta-thalassaemia at the globin gene level. Advances in clinical management, including blood transfusions and iron chelation, have improved life expectancy for thalassaemia major patients.
Developed countries have reduced haemoglobinopathy incidence through screening, education, genetic counseling, and prenatal diagnosis. However, these advanced strategies are not yet feasible for developing regions due to socioeconomic limitations.
Impact:
Enhanced understanding of the global distribution and genetic origins of sickle cell mutation and thalassaemia.
Improved insights into malaria resistance mechanisms linked to haemoglobinopathies.
Highlights the disparity in access to advanced diagnostic and management strategies between developed and developing countries.